Company / Income Tax
Edgewise Therapeutics, Inc. Income Tax History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$4.0K
FY2025
5-year range
$0 / $4.0K
FY2021-FY2025
Trend
+33.3%
vs FY2024
Sector context
#112 of 204
Health Care
What the data says
At $4,000, Edgewise Therapeutics, Inc.'s income tax ranks #93 of 204 in the Health Care sector.
Based on SEC 10-K filings.
$4,000 in FY2025.
Remained stable around $4,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#93 of 204 in Health CareTop 45% of 204This company $4.0K Sector average $118.7M
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, income tax increased 33.3% year-over-year.
- Ranks #112 out of 204 companies in the Health Care sector.
- Lowest income tax in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.82 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.0K | +33.3% |
| FY2024 | $3.0K | -25.0% |
| FY2023 | $4.0K | - |
| FY2022 | $0 | - |
| FY2021 | $0 | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026